Annual Drug Patent Expirations for RYZUMVI
Ryzumvi is a drug marketed by Ocuphire and is included in one NDA.
The generic ingredient in RYZUMVI is phentolamine mesylate. Additional details are available on the phentolamine mesylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
